CTBP1‑AS upregulation is associated with polycystic ovary syndrome and can be effectively downregulated by cryptotanshinone-Reference-Cited by-同舟云学术

CTBP1‑AS upregulation is associated with polycystic ovary syndrome and can be effectively downregulated by cryptotanshinone

Published:2022-06-01 Issue:1 Volume:26 Page:
ISSN:1791-2997
Container-title:Molecular Medicine Reports
language:
Short-container-title:Mol Med Rep

Author:

Wen Mingxiao¹,Dou Xiaoqing¹,Zhang Shuzhen¹,Wang Bin¹,Xu Jiangyan²,Zhang Wenchao¹,Wang Feifei¹

Affiliation:

1. Department of Gynecology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Zhejiang Provincial Hospital of Traditional Chinese Medicine, Hangzhou, Zhejiang 310060, P.R. China

2. Department of Clinical Laboratory, The First Affiliated Hospital of Zhejiang Chinese Medical University, Zhejiang Provincial Hospital of Traditional Chinese Medicine, Hangzhou, Zhejiang 310060, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,Genetics,Molecular Biology,Molecular Medicine,Biochemistry

Reference37 articles.

1. Metabolic syndrome: Polycystic ovary syndrome;Mortada;FP Essent,2015

2. Polycystic ovary syndrome and endometrial carcinoma;Hardiman;Lancet,2003

3. Do different diagnostic criteria impact polycystic ovary syndrome diagnosis for adolescents?;Akgül;J Pediatr Adolesc Gynecol,2018

4. Polycystic ovary syndrome: Etiology, pathogenesis and diagnosis;Goodarzi;Nat Rev Endocrinol,2011

5. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain;Asunción;J Clin Endocrinol Metab,2000

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study of NALT1 and CTBP1-AS1 lncRNAs expression levels in triple-negative breast cancer patients in the Iranian population;Gene Reports;2024-12

2. LncRNA CTBP1‐AS inhibits TP63‐mediated activation of S100A14 during prostate cancer progression;Cancer Science;2024-03-13

3. Current Advances in Cellular Approaches for Pathophysiology and Treatment of Polycystic Ovary Syndrome;Cells;2023-08-31